about
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA...
Read More
3.88
-0.12
(-3.00%)
4.7M
XNAS Volume
High vol.+gain this week
XNAS 08 May, 2026 4:10 PM (EDT)
Board Meeting
The next board meeting for Cabaletta Bio Inc is on 15 May 2026 for the purpose of Cabaletta Bio Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bullish
Cabaletta Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..